Huella digital
- 1 Perfiles similares
Colaboraciones y áreas de investigación principales de los últimos cinco años
-
NF2 loss malignantly transforms human pancreatic acinar cells and enhances cell fitness under environmental stress
Xu, Y., Nipper, M. H., Dominguez, A. A., He, C., Sharkey, F. E., Khan, S., Xu, H., Zhou, D., Zheng, L., Luan, Y., Liu, J. & Wang, P., ene 2 2026, En: The Journal of clinical investigation. 136, 1Producción científica: Article › revisión exhaustiva
Acceso abierto -
Discovery of PZ671, a highly potent and in vivo active CRBN-recruiting Bcl-xL degrader
Zhang, P., Thummuri, D., Hu, W., Khan, S., He, Y., Zhang, X., Pal, P., Lv, D., Zhou, D., Zheng, G. & Zhou, D., ago 13 2025, En: RSC Medicinal Chemistry. 16, 8, p. 3495-3506 12 p.Producción científica: Article › revisión exhaustiva
Acceso abierto1 !!Link opens in a new tab Cita (Scopus) -
Targeting DDR2 for Treating Pancreatic Cancer
Do, C. T. P., Venkata, P. P., Prochnau, J. Y., Singh, D., Timilsina, S., Subbarayalu, P., Medina, D., Abdulsahib, S., Nirzhor, S., Khan, S., Li, G., Polusani, S. R., Zhou, D., Wang, P., Chen, Y., Vadlamudi, R. K., Hart, M. J., Amaradhi, R., McHardy, S. F. & Rao, M. K., oct 1 2025, En: Molecular cancer therapeutics. 24, 10, p. 1570-1583 14 p.Producción científica: Article › revisión exhaustiva
-
PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer
Khan, S., Cao, L., Wiegand, J., Zhang, P., Zajac-Kaye, M., Kaye, F. J., Zheng, G. & Zhou, D., mar 2024, En: Cells. 13, 6, 528.Producción científica: Article › revisión exhaustiva
Acceso abierto21 !!Link opens in a new tab Citas (Scopus) -
Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice
Khan, S., Kellish, P., Connis, N., Thummuri, D., Wiegand, J., Zhang, P., Zhang, X., Budamagunta, V., Hua, N., Yang, Y., De, U., Jin, L., Zhang, W., Zheng, G., Hromas, R., Hann, C., Zajac-Kaye, M., Kaye, F. J. & Zhou, D., dic 2023, En: Cell Death Discovery. 9, 1, 1.Producción científica: Article › revisión exhaustiva
Acceso abierto33 !!Link opens in a new tab Citas (Scopus)
Conjuntos de datos
-
Additional file 2 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726547.v1, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726547/1
Dataset
-
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5075029.v1, https://springernature.figshare.com/collections/Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/5075029/1
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550
Dataset
-
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5075029, https://springernature.figshare.com/collections/Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/5075029
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550.v1, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550/1
Dataset